These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 1014497)

  • 1. [Bifunctional derivatives of N-nitroso-alkylurea].
    Emanuel' NM; Konovalova NP; D'iachkovskaia RF; Rozenberg AN
    Vopr Onkol; 1976; 22(10):72-7. PubMed ID: 1014497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a bifunctional derivative of nitrosoalkylurea on the growth of experimetal tumors].
    Vasil'eva LS; Gumanov LL; D'iachkovskaia RF; Konovalova NP; Surkova NI
    Izv Akad Nauk SSSR Biol; 1973; 5():737-9. PubMed ID: 4796871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dependence of the antitumor activity of nitroso alkyl urea derivatives on their chemical structure].
    Sharashidze LK; Turkiia NG; Lagidze DR; Adamiia IK; Asatiani VV
    Eksp Onkol; 1989; 11(2):62-5. PubMed ID: 2737133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicine-N-oxide: the antitumor principle of Heliotropium indicum.
    Kugelman M; Liu WC; Axelrod M; McBride TJ; Rao KV
    Lloydia; 1976; 39(2-3):125-8. PubMed ID: 948236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH; Zakhariev SG; Golovinsky EV
    Neoplasma; 1980; 27(2):137-42. PubMed ID: 7393353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of several new pentopyranosyl-chloroethylnitrosoureas].
    Grouiller A; Navarro ML; Nonga B; Molière P; Santini R; Voulot C; Pacheco H
    C R Seances Soc Biol Fil; 1987; 181(2):128-36. PubMed ID: 2957032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
    Ostrovskaia LA; Sokolova IS; Gorbacheva LB
    Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antineoplastic activity of testiphenon].
    Lagova ND; Sof'ina ZP; Shkodinskaia EN; Kurdiumova KN; Valueva IM
    Vopr Onkol; 1988; 34(11):1363-8. PubMed ID: 3201773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.
    Köpf-Maier P; Klapötke T
    Arzneimittelforschung; 1989 Apr; 39(4):488-90. PubMed ID: 2751735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alkyl nitrosoureidodioxans and alkyl nitrosoureidopropane diols -- new groups of antitumor compounds].
    Kon'kov SA; Stukov AN; Reztsova VV; Krylova IM; Ivin BA; VA Filov
    Vopr Onkol; 1998; 44(1):97-9. PubMed ID: 9578740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor properties of selected 1,2,4-triazine derivatives.
    Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
    Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
    J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
    Sava G; Giraldi T; Baldini L
    Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Johnson RK; Inouye T; Goldin A; Stark GR
    Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of experimental brain tumors: preliminary studies.
    Schwartz J; Kott E; Elizan TS
    Mt Sinai J Med; 1974; 41(1):205-10. PubMed ID: 4361051
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.